December 22, 2025

Ants may hold solution to human superbug, researchers discover

December 22, 2025 / Research update / InnovateMed Author / ant, human superbug

by Auburn University College of Agriculture edited by Gaby Clark, reviewed by Robert Egan Editors’ notes A team of researchers led by Auburn University Assistant Professor Clint Penick studied ants like these, which are easily found in the Southeastern United States. Credit: Luke Edenborough Has a crucial component to the development of human medicine been hiding under […]

Ants may hold solution to human superbug, researchers discover Read More »

Can Soybean Oil Contribute to Obesity?

December 22, 2025 / Research update / InnovateMed Author / soya bean oil

Batya Swift Yasgur, MA, LSW December 12, 2025 Soybean oil (SO), one of the most widely used cooking oils in the US and a staple in many processed foods, is regarded as benign or even beneficial when compared with saturated fat. But new research suggests SO may contribute to weight gain and postulates a potential

Can Soybean Oil Contribute to Obesity? Read More »

Scientists identify first non-coding gene that controls cell size

December 22, 2025 / Research update / InnovateMed Author / coding gene

by The Hospital for Sick Children edited by Gaby Clark, reviewed by Robert Egan Editors’ notes A hairpin loop from a pre-mRNA. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue). Note that this is a single strand of RNA that folds back upon itself. Credit: Vossman/ Wikipedia What keeps our cells the right size? Scientists have

Scientists identify first non-coding gene that controls cell size Read More »

Orforglipron Helps Maintain Weight Loss After Injectables

December 22, 2025 / Clinical Practice / InnovateMed Author / orforglipron

Marilynn Larkin December 18, 2025 Topline results from the ATTAIN-MAINTAIN trial show that orforglipron, an investigational oral GLP-1 receptor agonist, helps people maintain weight loss after switching from an injectable, Eli Lilly announced today. The phase 3 placebo-controlled study evaluated orforglipron for weight maintenance over 52 weeks after initial treatment for 72 weeks with the

Orforglipron Helps Maintain Weight Loss After Injectables Read More »

Women are better at recognizing illness in faces compared to men, study finds

December 22, 2025 / Patient education / InnovateMed Author / illness

by Krystal Kasal, Medical Xpress edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Examples of healthy (top) and sick (bottom) face stimuli. Credit: Evolution and Human Behavior (2026). DOI: 10.1016/j.evolhumbehav.2025.106803 Most people have either been told that they don’t look well when they were sick, or thought that someone else looked ill at some point in their lives.

Women are better at recognizing illness in faces compared to men, study finds Read More »

Inflammation-induced metabolic shifts linked to brain disorders

December 22, 2025 / Research update / InnovateMed Author / brain disorder

by Kindai University edited by Robert Egan, reviewed by Andrew Zinin Editors’ notes This illustration depicts the experimental workflow using a mouse model of LPS-induced acute systemic inflammation and PiTMaP-based metabolomics. Metabolic profiles were compared across major brain regions—including the cerebrum, hippocampus, cerebellum, and hypothalamus—revealing that only the cerebrum showed marked metabolic alterations. Projection to latent structures-discriminant

Inflammation-induced metabolic shifts linked to brain disorders Read More »

Eczema injectable drug provides quick itch relief, clinical trial results show

December 22, 2025 / Clinical Practice / InnovateMed Author / eczema

by Dennis Thompson edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new study says. Nemolizumab (Nemluvio) relieved itchiness within two days for three times as many patients as a placebo, researchers reported in the Journal of the European Academy

Eczema injectable drug provides quick itch relief, clinical trial results show Read More »

You finally got a doctor’s appointment. Here’s how to get the most out of it

December 22, 2025 / Patient education / InnovateMed Author / appointment

by Lauran Neergaard edited by Andrew Zinin Editors’ notes An exam room at a medical clinic in Detroit on July 29, 2015. Credit: Charles V. Tines/Detroit News via AP, File It’s not unusual for a 20-something to text Mom in a panic from the doctor’s office, seeking help answering a question. And patients of any age

You finally got a doctor’s appointment. Here’s how to get the most out of it Read More »

The role of neuroinflammation in progressive multiple sclerosis

December 22, 2025 / Clinical Practice / InnovateMed Author / multiple sclerosis

by Ingrid Fadelli, Medical Xpress edited by Sadie Harley, reviewed by Robert Egan Editors’ notes OxPC deposition induces chronic demyelination, neuroinflammation, endogenous lipid peroxidation and neurodegeneration in the CNS. Credit: Nature Neuroscience (2025). DOI: 10.1038/s41593-025-02113-y. Multiple sclerosis (MS) is a disorder that prompts the body’s immune system to attack myelin, the protective sheath covering nerve cells in the brain, optic

The role of neuroinflammation in progressive multiple sclerosis Read More »

Brie, cheddar, and other high-fat cheeses linked to lower dementia risk

December 22, 2025 / Patient education / InnovateMed Author / dementia risk

But don’t load up that cheese plate just yet. Laura Baisas Published Dec 17, 2025 4:00 PM EST High-fat cheeses have more than 20 percent fat. Deposit Photos Get the Popular Science daily newsletter💡 Breakthroughs, discoveries, and DIY tips sent every weekday. Email addressSign up Terms of Service and Privacy Policy. It’s been found in ancient human feces. The U.S.

Brie, cheddar, and other high-fat cheeses linked to lower dementia risk Read More »